CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 71 filers reported holding CULLINAN ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $359,303 | -40.3% | 39,702 | -29.0% | 0.00% | -100.0% |
Q2 2023 | $601,968 | -20.0% | 55,945 | -24.0% | 0.00% | 0.0% |
Q1 2023 | $752,642 | -28.4% | 73,572 | -26.2% | 0.00% | 0.0% |
Q4 2022 | $1,051,846 | +5.9% | 99,701 | +28.7% | 0.00% | 0.0% |
Q3 2022 | $993,000 | -18.5% | 77,440 | -18.5% | 0.00% | 0.0% |
Q2 2022 | $1,218,000 | -21.6% | 94,986 | +57.5% | 0.00% | 0.0% |
Q2 2021 | $1,553,000 | -41.8% | 60,319 | -5.8% | 0.00% | -66.7% |
Q1 2021 | $2,668,000 | – | 64,033 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 7,648,268 | $118,013,000 | 21.52% |
CHI Advisors LLC | 2,476,720 | $38,215,000 | 12.68% |
Nextech Invest Ltd. | 1,221,145 | $18,842,000 | 4.96% |
Foresite Capital Management V, LLC | 1,143,006 | $17,637,000 | 4.33% |
Foresite Capital Opportunity Management V, LLC | 381,002 | $5,879,000 | 3.94% |
BVF INC/IL | 5,369,459 | $82,851,000 | 3.01% |
Boxer Capital, LLC | 1,074,082 | $16,573,000 | 0.64% |
Logos Global Management LP | 288,458 | $4,450,000 | 0.46% |
Birchview Capital, LP | 45,114 | $696,000 | 0.45% |
Eventide Asset Management | 1,440,145 | $21,665,000 | 0.28% |